Cytomel (Liothyronine) Cost in New Jersey 2026

What Liothyronine (Cytomel) Actually Costs in New Jersey Right Now

Generic liothyronine at New Jersey retail pharmacies averages about $35 per month in 2026 for a standard 25 mcg once-daily supply. Brand-name Cytomel carries a manufacturer list price near $120 per month, though almost no cash-pay patient pays that figure after discount programs. The gap between brand and generic is wide enough that most prescribers and pharmacists default to generic without discussion.

Brand vs. Generic Price Breakdown

Pfizer manufactures Cytomel in 5 mcg, 25 mcg, and 50 mcg tablets. Generic liothyronine sodium, produced by Mylan, Lannett, and Jerome Stevens Pharmaceuticals, is bioequivalent under FDA standards and carries the same approved indication. FDA bioequivalence requirements are codified in 21 CFR Part 320.

At major New Jersey chains including CVS, Walgreens, and RiteAid, a 30-tablet supply of generic liothyronine 25 mcg runs roughly:

• CVS cash price: $38, $44 without discount card
• Walgreens cash price: $36, $42 without discount card
• GoodRx-applied price at participating NJ pharmacies: $19, $28 depending on dose and location
• Costco (open to non-members for pharmacy in NJ): $22, $30

These figures shift slightly by zip code. Urban Northern NJ pharmacies (Essex, Hudson, Bergen counties) tend to price marginally higher than South Jersey rural independents.

How Dose Affects Total Monthly Cost

Liothyronine is frequently prescribed at 25 mcg once daily as a hypothyroidism adjunct alongside levothyroxine. Some patients receive twice-daily split dosing, which doubles the tablet count and monthly cost. Bunevicius et al. (NEJM, 1999, N=33) demonstrated that partial substitution of T4 with T3 improved mood and neuropsychological function compared with T4 alone, a finding that continues to drive combination therapy prescribing despite ongoing guideline debate.

At 25 mcg twice daily (60 tablets/month), expect to add roughly 50 to 80% to the single-dose monthly cost, putting generic cash price near $50, $65 at most NJ pharmacies.

New Jersey Medicaid Coverage for Liothyronine

NJ FamilyCare (New Jersey's Medicaid program) covers liothyronine sodium on its preferred drug list with a prior authorization requirement. Without PA approval, pharmacies will reject the claim. The NJ FamilyCare Preferred Drug List is published by the NJ Division of Medical Assistance and Health Services.

Prior Authorization Criteria

To obtain PA for liothyronine under NJ Medicaid, the prescribing clinician typically must document:

• A confirmed diagnosis of hypothyroidism (ICD-10 E03.9 or related)
• That levothyroxine monotherapy produced inadequate symptom control or laboratory normalization
• That the prescriber is a licensed NJ practitioner with an active DEA/NPI number

Approvals are generally issued for 12 months with annual renewal. Denial rates vary by managed care organization. NJ Medicaid members enrolled in a managed care plan (Horizon NJ Health, Wellcare NJ, or Aetna Better Health NJ) must submit PA through that plan's formulary process rather than directly to DMAHS.

What Medicaid Pays After PA Approval

Once approved, NJ Medicaid members pay $1, $3 in copay per 30-day fill for generic liothyronine. Brand Cytomel may require step-therapy documentation showing generic failure before coverage is extended to the higher-cost brand. Medicaid prescription drug coverage rules follow CMS guidance under 42 CFR Part 447 Subpart E.

Is Compounded Liothyronine T3 Legal in New Jersey?

Yes. Compounded liothyronine T3 is legal in New Jersey when prepared by a state-licensed 503A pharmacy operating under valid prescription for an individual patient. FDA 503A regulations govern patient-specific compounded preparations and exempt them from standard new drug approval requirements under FDCA Section 503A.

503A vs. 503B: What the Difference Means for NJ Patients

A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis. A 503B outsourcing facility produces larger batches for distribution to clinicians or health systems. Most NJ patients receiving compounded liothyronine obtain it through 503A retail compounding pharmacies.

NJ Board of Pharmacy licenses compounding pharmacies under N.J.A.C. 13:39-10. A pharmacy must hold an active NJ compounding license and may only compound liothyronine using USP-grade active pharmaceutical ingredient (API) from an FDA-registered supplier.

Why Some Patients Choose Compounded T3

Compounded liothyronine allows dose customization. If a patient requires 12.5 mcg (not commercially available) or a sustained-release formulation, a 503A pharmacy can prepare it. The American Thyroid Association's 2019 guidelines note that evidence for sustained-release T3 remains insufficient and urge caution, recommending standard immediate-release preparations as first-line.

Cost at NJ-licensed 503A pharmacies runs roughly $40 per month for a standard compounded T3 dose, which is modestly above the $35 generic retail average but below brand Cytomel pricing.

Telehealth Prescribing of Compounded Liothyronine in NJ

A telehealth clinician licensed in New Jersey may prescribe compounded liothyronine to a New Jersey patient. The prescription must meet standard NJ Rx requirements: prescriber NPI, patient name, date, drug strength, quantity, and directions. NJ telehealth prescribing authority is established under N.J.S.A. 45:1-62, which prohibits prescribing without a valid patient-prescriber relationship but does not require an in-person visit.

Insurance Coverage for Cytomel (Liothyronine) in New Jersey

Most commercial insurance plans sold in New Jersey cover generic liothyronine at Tier 1 or Tier 2. Brand Cytomel is more commonly placed at Tier 3 or Tier 4, with non-preferred brand copays of $50, $150 per fill depending on plan design.

ACA Marketplace Plans

New Jersey residents buying coverage through GetCoveredNJ use Silver or Gold plans from Horizon BCBS NJ, Oscar Health, and AmeriHealth. All three carriers list generic liothyronine as a covered drug on their 2026 formularies at Tier 1 ($0, $10 copay) for members who have met their deductible. The ACA essential health benefits requirement does not mandate specific drugs but requires plans to cover at least one drug in each therapeutic category, per CMS.

Employer-Sponsored Plans

New Jersey has the third-highest rate of employer-sponsored insurance in the United States, per the CDC National Center for Health Statistics NHIS 2023 data. Most large-group employer plans in NJ use a PBM (CVS Caremark, Express Scripts, or OptumRx) whose formularies treat generic liothyronine as Tier 1 preferred. Expect $0, $15 copay per 30-day fill after deductible.

Medicare Part D in New Jersey

Medicare Part D plans available in NJ in 2026 (including AARP MedicareRx, Humana Walmart Value Rx, and Wellcare Value Script) cover generic liothyronine at Tier 1 or Tier 2. CMS Medicare Part D formulary requirements are published annually; liothyronine is classified in the thyroid agent category. During the standard benefit phase, a Tier 1 generic copay runs $0, $10. Patients in the coverage gap prior to 2025 IRA changes faced higher cost-sharing, but the Inflation Reduction Act capped out-of-pocket Part D spending at $2,000 annually starting 2025.

The Cheapest Ways to Get Liothyronine in New Jersey

Generic liothyronine at $35 per month average is already affordable for most patients. Several strategies cut that further.

Discount Cards and Coupon Programs

GoodRx consistently offers the lowest verified prices at NJ pharmacies for liothyronine. In January 2026, GoodRx showed:

• $19.47 for liothyronine 25 mcg, 30 tablets at ShopRite Pharmacy (Bergen County)
• $21.80 at Costco Pharmacy (multiple NJ locations)
• $27.65 at CVS with GoodRx coupon applied

RxSaver and NeedyMeds also provide comparable coupon codes accepted at independent NJ pharmacies. These programs are free to use and require no enrollment.

Pfizer Savings Card for Brand Cytomel

Pfizer offers a savings card for commercially insured patients that may reduce brand Cytomel out-of-pocket cost. Details are available on the Pfizer Cytomel product page via the FDA label. Patients without commercial insurance (Medicaid, Medicare, uninsured) are generally not eligible for manufacturer savings cards under OIG guidance. The card typically caps monthly cost at $25, $30 for eligible patients.

90-Day Supply Savings

Mail-order pharmacy (through insurance PBM) or 90-day retail supply reduces per-unit cost by 10 to 25%. A 90-day supply of generic liothyronine 25 mcg via Express Scripts mail order runs approximately $30, $45 total for commercially insured NJ members at Tier 1, versus $45, $90 at retail for the same quantity.

Patient Assistance Programs

Pfizer's patient assistance program (PAP) provides free brand Cytomel to uninsured or underinsured patients meeting income criteria (generally <400% of federal poverty level). Applications are submitted through Pfizer RxPathways. Processing takes 2 to 4 weeks. Generic manufacturers offer limited PAP programs; the discount card route is faster for generic liothyronine.

Telehealth Access to Liothyronine Prescriptions in New Jersey

New Jersey allows telehealth prescribing of non-controlled substances including liothyronine without requiring an in-person visit, provided the prescriber holds an active NJ license and conducts a synchronous audio-video encounter. NJ Executive Order 103 (2020) expanded telehealth access; the Legislature codified permanent telehealth authority under P.L. 2021, c. 310.

What a Telehealth Thyroid Evaluation Includes

A standard telehealth visit for liothyronine initiation at a credentialed NJ telehealth practice includes:

• Review of prior TSH, free T4, and free T3 laboratory results (ordered at any LabCorp or Quest NJ location)
• Symptom assessment using validated tools such as the Thyroid Symptom Score
• Discussion of combination T4/T3 therapy rationale
• Electronic Rx sent to patient's preferred NJ pharmacy

The Endocrine Society's 2019 Clinical Practice Guideline on hypothyroidism management states: "We recommend against the routine use of combination T4 and T3 therapy...however, a trial of combination therapy may be considered in patients with persistent symptoms on T4 monotherapy." This guideline language gives NJ telehealth prescribers clinical footing to initiate liothyronine when levothyroxine alone has not resolved symptoms.

Lab Monitoring Requirements

Starting liothyronine requires baseline TSH and free T3. After dose initiation or adjustment, repeat labs are recommended at 6 to 8 weeks. The American Thyroid Association recommends maintaining serum TSH within the reference range during combination T3/T4 therapy. NJ LabCorp and Quest locations accept standing orders from telehealth prescribers.

Clinical Background: Why Liothyronine Is Prescribed

Liothyronine sodium is the synthetic form of triiodothyronine (T3), the biologically active thyroid hormone. The thyroid gland and peripheral tissues convert levothyroxine (T4) to T3 via deiodinase enzymes. Genetic polymorphisms in type 2 deiodinase (DIO2) have been associated with reduced T4-to-T3 conversion efficiency in a subset of patients, per Wouters et al. (PLOS ONE, 2019).

Approved Indications per FDA Label

The FDA-approved Cytomel label covers:

1. Hypothyroidism (as monotherapy or adjunct)
2. Pituitary TSH suppression
3. Diagnostic use in T3 suppression testing

The full Cytomel prescribing information is available via FDA Drugs@FDA.

Pharmacokinetic Rationale for Twice-Daily Dosing

T3 has a half-life of approximately 2.5 days, shorter than T4's 7-day half-life. This pharmacokinetic difference means serum T3 peaks within 2 to 4 hours of oral liothyronine ingestion and declines more rapidly than T4, per data summarized in the FDA label. Twice-daily dosing flattens the peak-trough curve and may reduce palpitation risk, which is why many NJ endocrinologists split the daily dose.

Cardiovascular Monitoring Considerations

Excess T3 increases resting heart rate and may provoke atrial fibrillation in susceptible patients. A 2018 study in JAMA Internal Medicine (N=174,153) found that TSH suppression below 0.1 mIU/L was associated with a 45% higher risk of atrial fibrillation. NJ prescribers initiating liothyronine typically obtain a baseline ECG in patients over 60 or with known cardiac history.

NJ-Specific Prescribing Field for Liothyronine

NJ has more endocrinologists per capita than the national average. The 2024 AAMC workforce data places New Jersey at 8.2 endocrinologists per 100,000 residents versus a national average of 5.9. Despite this density, wait times for new-patient endocrinology appointments in Northern NJ (Essex, Morris, Bergen) frequently exceed 3 to 4 months. Telehealth fills this gap for patients seeking liothyronine without an extended wait.

Independent NJ compounding pharmacies with active 503A licensure that commonly fill T3 prescriptions include practices in Monmouth, Middlesex, and Ocean counties. Patients should verify current licensure with the NJ Division of Consumer Affairs pharmacy lookup tool before filling any compounded prescription.

The Endocrine Society's position statement on compounded thyroid hormone preparations cautions that compounded products lack the manufacturing consistency of FDA-approved drugs and should not be considered interchangeable. This does not prohibit their use but does underscore the importance of sourcing from high-quality, licensed NJ pharmacies.

Cost Comparison Table: Liothyronine Options in NJ (2026)

| Source | Monthly Cost (25 mcg QD) | Insurance Accepted | |---|---|---| | Brand Cytomel (retail) | ~$120 list / $25, $30 with Pfizer card | Commercial only for card | | Generic (retail, no discount) | $35, $44 | Yes | | Generic + GoodRx | $19, $28 | No (cash only) | | Compounded 503A NJ | ~$40 | Rarely; some FSA/HSA eligible | | NJ Medicaid (after PA) | $1, $3 copay | NJ FamilyCare members | | Medicare Part D Tier 1 | $0, $10 copay | Medicare beneficiaries |